Popular Articles

Link Unraveled Between Chromosomal Instability And Centrosome Defects In Cancer Cells
In a new study, Dana-Farber Cancer Institute scientists disprove a century-old theory about why cancer cells often have too many or too few chromosomes, and show that the actual reason may hold the key to a novel approach to cancer therapy.

Eye Disorder Research Benefits From Grant
Researchers at the Peninsula Medical School in Plymouth and Exeter have received a grant of ÷£9,600 from the Northcott Devon Medical Foundation to continue its research into the genetic causes of eye movement disorders.
News of the day
Miami-Dade, Blue Cross Announce Low-Cost PPO Aimed At County's Uninsured
Florida"s Miami-Dade County and BlueCross BlueShield of Florida on Tuesday announced a new low-cost health plan, called Miami-Dade Blue, aimed at helping the estimated 600,000 uninsured county residents, the Miami Herald reports. The plan -- which costs taxpayers nothing -- is a traditional PPO, with no pre-approvals or referrals and will cost a healthy 35-year-old male about $100 per month. Miami-Dade Blue has a $250 deductible and will cover 90% of in-network hospital costs and 100% of fees for in-network lab tests after the deductible is met. The copayment for generic drugs is $10 per prescription; the plan will not offer coverage for brand-name prescriptions.The plan is being offered to individuals younger than age 65 and to small employers with up to 50 workers. Businesses will be guaranteed coverage if 70% of employees take part in the plan and the owner pays at least 50% of the premiums; however, individuals with costly pre-existing health conditions likely will be denied coverage. The plan has an annual out-of-pocket limit of $2,500 and a lifetime benefit of $5 million. About 1,500 physicians agreed to be part of the Miami-Dade Blue network, while 20 clinics and seven hospitals are in the plan"s network (Dorschner, Miami Herald, 5/27).
Public Health

Maryland Stem Cell Research Commission

What The Maryland Stem Cell Research Commission (Commission) will hold a regular meeting. Part of this meeting may be conducted in closed session (see "Note"). During this meeting, the Commission is requesting to hear comments from the public. Those wishing to address the Commission on the topic of stem cell research in the State of Maryland must first coordinate a speaking time with Commission administration. Members of the public who wish to be heard should email mscrfinfo@marylandtedco.org. Established as an independent unit within the Maryland Technology Development Corporation (TEDCO), the Commission has set up criteria, standards and requirements to administer the Maryland Stem Cell Research Fund in accordance with the Maryland Stem Cell Research Act of 2006. The Maryland Stem Cell Research Fund has been established to promote state-funded stem cell research. With a $15.4 million budget for FY 2010, the Commission will support grants to public and private entities in the State. For more information about the Maryland Stem Cell Research Fund and a list of Commission members, please visit http://www.mscrf.org. Note The Commission may, in open session, follow the required procedures to go into closed session, which will be limited to matters that are permissibly discussed in closed session under the Maryland Open Meetings Act. For more information, please refer to http://www.oag.state.md.us/opengov/index.htm. When Thursday, June 4, 2009 Time 2 p.m. - 5 p.m. Where UMB BioPark - Building 2 Conference Room 801 West Baltimore Street Baltimore, MD 21201 Directions Visit http://www.umbbiopark.com/contact.aspx?details=0 for directions. The parking garage is located on West Baltimore Street. Maryland Stem Cell Research Fund


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):